文献速递新生儿儿童血液肿瘤与免疫

新生儿输血实践差异研究

Variation in Neonatal Transfusion Practice.
PubMed 文献 · J Pediatr · 2021-04-07

输血前血红蛋白、血小板计数和国际标准化比值存在广泛差异,提示美国大量新生儿输血在高于现有最佳证据支持的阈值下进行,存在改善患者血液管理的机会。

要点

  • 胎龄越小输血发生率越高:<27周达80%,≥37周仅0.5%。
  • 输血前血红蛋白中位数11.2 g/dL,不同胎龄组范围10.5-13.0 g/dL。
  • 大量新生儿输血阈值可能高于最佳证据支持水平。

核心结论

  • 新生儿输血前血红蛋白、血小板计数和国际标准化比值存在广泛差异。
  • 美国大量新生儿输血在高于现有最佳证据支持的阈值下进行。
  • 研究结果提示存在改善新生儿患者血液管理的机会。

研究设计与样本

  • 回顾性队列研究,使用2013至2016年美国7家地理分布多样的学术和社区医院参与REDS-III的数据。
  • 输血前血液学值选取最接近每次输血且不超过24小时前的检测结果。

主要发现

  • 整个队列输血前血红蛋白中位数为11.2 g/dL(第10-90百分位8.8-14.1)。
  • 输血前血红蛋白中位数从<27周组的10.5 g/dL(8.8-12.3)到足月组的13.0 g/dL(10.5-15.5)不等。
  • 整个队列输血前血小板计数中位数为71×10^9/L(第10-90百分位26-135),所有胎龄组中位数均>45。
  • 整个队列输血前国际标准化比值中位数为1.7(第10-90百分位1.2-2.8)。

关键数值与推荐

  • 输血前血红蛋白中位数:整个队列11.2 g/dL(10th-90th百分位8.8-14.1)。
  • 输血前血红蛋白中位数:<27周组10.5 g/dL(8.8-12.3),足月组13.0 g/dL(10.5-15.5)。
  • 输血前血小板计数中位数:整个队列71×10^9/L(10th-90th百分位26-135)。
  • 输血前国际标准化比值中位数:整个队列1.7(10th-90th百分位1.2-2.8)。

临床怎么用

  • 临床医生应了解不同胎龄新生儿输血前血液学值存在广泛差异。
  • 输血决策时应参考现有最佳证据支持的阈值,避免在过高阈值下进行输血。
  • 可关注患者血液管理以优化新生儿输血实践。

局限性

  • 回顾性队列研究设计可能受数据记录完整性和混杂因素影响。
  • 数据仅来自7家美国医院,外推性需谨慎。
  • 输血前血液学值选取距输血24小时内的检测,可能存在时间差异影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the incidence of blood product transfusion, including red blood cells, platelets, and plasma, and characterize pretransfusion hematologic values for infants during their initial hospitalization after birth. STUDY DESIGN: Retrospective cohort study using data from 7 geographically diverse US academic and community hospitals that participated in the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) from 2013 to 2016. Pretransfusion hematologic values were evaluated closest to each transfusion and no more than 24 hours beforehand. RESULTS: Data from 60 243 infants were evaluated. The incidence of any transfusion differed by gestational age (P < .0001), with 80% (95% CI 76%-84%) transfused at <27 weeks of gestation (n = 329) and 0.5% (95% CI 0.5%-0.6%) transfused at ≥37 weeks of gestation (n = 53 919). The median pretransfusion hemoglobin was 11.2 g/dL (10th-90th percentile 8.8-14.1) for the entire cohort, ranging from 10.5 g/dL (8.8-12.3) for infants born extremely preterm at <27 weeks of gestation to 13.0 g/dL (10.5-15.5) for infants born at term. The median pretransfusion platelet count (×109/L) was 71 (10th-90th percentile 26-135) for the entire cohort, and was >45 for all gestational age groups examined. The median pretransfusion international normalized ratio for the entire cohort was 1.7 (10th-90th percentile 1.2-2.8). CONCLUSIONS: There is wide variability in pretransfusion hemoglobin, platelet count, and international normalized ratio values for neonatal transfusions. Our findings suggest that a large proportion of neonatal transfusions in the US are administered at thresholds greater than supported by the best-available evidence and highlight an opportunity for improved patient blood management.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Patel RM, Hendrickson JE, Nellis ME, et al. Variation in Neonatal Transfusion Practice. J Pediatr. 2021. PMID: 33836184. doi:10.1016/j.jpeds.2021.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。